Switching Between Biologics and Targeted Synthetic Therapies Due to Inefficacy in Psoriatic Arthritis

被引:0
|
作者
Freites Nunez, Dalifer [1 ]
Rodriguez Laguna, Maria [1 ]
Hormigos Martin, Cristina [1 ]
Rosales, Zulema [1 ]
Leon, Leticia [2 ]
Candelas, Gloria [1 ]
Rubio, Daniel [3 ]
Otazu, Jose [1 ]
Fernandez, Benjamin [1 ]
Abasolo, Lydia [1 ]
机构
[1] Hosp Clin San Carlos, Madrid, Spain
[2] Fdn Invest Biomed Hosp Clin San Carlos, Madrid, Spain
[3] Univ Complutense Madrid, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2244
引用
收藏
页码:4438 / 4440
页数:3
相关论文
共 50 条
  • [31] TREATMENT OF MODERATE-TO-SEVERE ACTIVE PSORIATIC ARTHRITIS: COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ANALYSIS OF BIOLOGICS AND TARGETED THERAPIES APPROVED IN THE RUSSIAN FEDERATION
    Rudakova, A.
    Tolkacheva, D.
    Sokolova, V
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S117 - S118
  • [32] Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience
    Coates, L. C.
    Cawkwell, L. S.
    Ng, N. W. F.
    Bennett, A. N.
    Bryer, D. J.
    Fraser, A. D.
    Emery, P.
    Marzo-Ortega, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (05) : 717 - 719
  • [33] Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
    Cantini, Fabrizio
    Nannini, Carlotta
    Niccoli, Laura
    Petrone, Linda
    Ippolito, Giuseppe
    Goletti, Delia
    [J]. MEDIATORS OF INFLAMMATION, 2017, 2017
  • [34] Primary non-adherence to biologics and immunomodulatory therapies for rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis using linked EHR and pharmacy claims data
    Curtis, Jeffrey
    Su, Yujie
    Clinton, Cassie
    Stewart, Patrick
    England, Bryant
    Xie, Fenglong
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 530 - 531
  • [35] Primary Non-adherence to Biologics and Immunomodulatory Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis Using Linked EHR and Pharmacy Claims Data
    Curtis, Jeffrey
    Su, Yujie
    Clinton, Cassie
    Stewart, Patrick
    England, Bryant
    Buekelman, Tim
    Xie, Fenglong
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4360 - 4362
  • [36] Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
    Tillett, William
    Allen, Alexander
    Tucker, Laura
    Chandler, David
    Ciurtin, Coziana
    Davis, Charlotte
    Dick, Andrew
    Foulkes, Amy
    Gullick, Nicola
    Helliwell, Philip
    Jadon, Deepak
    Jones, Gareth
    Kyle, Stuart
    Madhok, Vishnu
    McHugh, Neil
    Parkinson, Andrew
    Raine, Tim
    Siebert, Stefan
    Smith, Catherine
    Coates, Laura C.
    [J]. RHEUMATOLOGY, 2021, 60 (04) : 1588 - 1592
  • [37] Changing Patterns of Use of Biologic/Targeted Synthetic DMARDs in Psoriatic Arthritis: An Analysis of the OPAL Dataset
    Ciciriello, Sabina
    Smith, Tegan
    Littlejohn, Geoffrey
    Tymms, Kathleen
    Mathers, David
    Cooley, Helen
    Griffiths, Hedley
    OSullivan, Catherine
    Youssef, Peter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [38] What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis?
    Sunzini, Flavia
    D'Antonio, Arianna
    Fatica, Mauro
    Triggianese, Paola
    Conigliaro, Paola
    Greco, Elisabetta
    Bergamini, Alberto
    Chimenti, Maria Sole
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (12) : 1545 - 1559
  • [39] TREATMENT RETENTION AND SAFETY OF IXEKIZUMAB IN A POPULATION WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC AND TARGETED SYNTHETIC DMARDS
    Brana Abascal, I.
    Burger, S.
    Gonzalez del Pozo, P.
    Pardo Campo, E.
    Alonso Castro, S.
    Fernandez, S.
    Jirout, F.
    Zapico, I.
    Alperi-Lopez, M.
    Queiro Silva, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1783 - 1783
  • [40] The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
    Tucker, Laura
    Allen, Alexander
    Chandler, David
    Ciurtin, Coziana
    Dick, Andrew
    Foulkes, Amy
    Gullick, Nicola
    Helliwell, Philip
    Jadon, Deepak
    Jones, Gareth
    Kyle, Stuart
    Madhok, Vishnu
    McHugh, Neil
    Parkinson, Andrew
    Raine, Tim
    Siebert, Stefan
    Smith, Catherine
    Tillett, William
    Coates, Laura C.
    [J]. RHEUMATOLOGY, 2022, 61 (09) : E255 - E266